A citation-based method for searching scientific literature

C M Balch, S J Soong, J E Gershenwald, J F Thompson, D S Reintgen, N Cascinelli, M Urist, K M McMasters, M I Ross, J M Kirkwood, M B Atkins, J A Thompson, D G Coit, D Byrd, R Desmond, Y Zhang, P Y Liu, G H Lyman, A Morabito. J Clin Oncol 2001
Times Cited: 1702







List of co-cited articles
442 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harold J Hoekstra, Constantine P Karakousis, Christopher A Puleo, Brendon J Coventry,[...]. N Engl J Med 2014
774
28

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
839
28

Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
26

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Mark B Faries, John F Thompson, Alistair J Cochran, Robert H Andtbacka, Nicola Mozzillo, Jonathan S Zager, Tiina Jahkola, Tawnya L Bowles, Alessandro Testori, Peter D Beitsch,[...]. N Engl J Med 2017
570
22

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Jeffrey Weber, Mario Mandala, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas,[...]. N Engl J Med 2017
975
15

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
641
14

Sentinel-node biopsy or nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Robert Elashoff, Richard Essner, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra, Constantine P Karakousis,[...]. N Engl J Med 2006
13

Technical details of intraoperative lymphatic mapping for early stage melanoma.
D L Morton, D R Wen, J H Wong, J S Economou, L A Cagle, F K Storm, L J Foshag, A J Cochran. Arch Surg 1992
12

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S Carlino,[...]. N Engl J Med 2018
739
11

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
J E Gershenwald, W Thompson, P F Mansfield, J E Lee, M I Colome, C H Tseng, J J Lee, C M Balch, D S Reintgen, M I Ross. J Clin Oncol 1999
935
11

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
Jeffrey E Gershenwald, Richard A Scolyer. Ann Surg Oncol 2018
147
11

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
C M Balch, A C Buzaid, S J Soong, M B Atkins, N Cascinelli, D G Coit, I D Fleming, J E Gershenwald, A Houghton, J M Kirkwood,[...]. J Clin Oncol 2001
10

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, Werner Hohenberger, Norbert Brockmeyer, Carola Berking, Cord Sunderkötter, Martin Kaatz, Klaus-Werner Schulte, Percy Lehmann,[...]. Lancet Oncol 2016
326
9

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
Manuela F Azzola, Helen M Shaw, John F Thompson, Seng-Jaw Soong, Richard A Scolyer, Geoffrey F Watson, Marjorie H Colman, Yuting Zhang. Cancer 2003
270
9

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Konstantinos Lasithiotakis, Ulrike Leiter, Friedegund Meier, Thomas Eigentler, Gizela Metzler, Matthias Moehrle, Helmut Breuninger, Claus Garbe. Cancer 2008
169
8


Age as a prognostic factor in patients with localized melanoma and regional metastases.
Charles M Balch, Seng-jaw Soong, Jeffrey E Gershenwald, John F Thompson, Daniel G Coit, Michael B Atkins, Shouluan Ding, Alistair J Cochran, Alexander M M Eggermont, Keith T Flaherty,[...]. Ann Surg Oncol 2013
94
7

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards,[...]. N Engl J Med 2016
738
7

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015
7

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
7

Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
Florentien E M In 't Hout, Lauren E Haydu, Rajmohan Murali, Johannes J Bonenkamp, John F Thompson, Richard A Scolyer. Ann Surg 2012
33
21

Melanoma.
Dirk Schadendorf, Alexander C J van Akkooi, Carola Berking, Klaus G Griewank, Ralf Gutzmer, Axel Hauschild, Andreas Stang, Alexander Roesch, Selma Ugurel. Lancet 2018
348
7

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
John F Thompson, Seng-Jaw Soong, Charles M Balch, Jeffrey E Gershenwald, Shouluan Ding, Daniel G Coit, Keith T Flaherty, Phyllis A Gimotty, Timothy Johnson, Marcella M Johnson,[...]. J Clin Oncol 2011
228
7

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Donald L Morton, Alistair J Cochran, John F Thompson, Robert Elashoff, Richard Essner, Edwin C Glass, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra,[...]. Ann Surg 2005
485
6


Gender-related differences in outcome for melanoma patients.
Charles R Scoggins, Merrick I Ross, Douglas S Reintgen, R Dirk Noyes, James S Goydos, Peter D Beitsch, Marshall M Urist, Stephan Ariyan, Jeffrey J Sussman, Michael J Edwards,[...]. Ann Surg 2006
125
6

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Michael A Henderson, Bryan H Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers,[...]. Lancet Oncol 2015
96
6

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
6

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Caroline Robert, Luc Thomas, Igor Bondarenko, Steven O'Day, Jeffrey Weber, Claus Garbe, Celeste Lebbe, Jean-François Baurain, Alessandro Testori, Jean-Jacques Grob,[...]. N Engl J Med 2011
6

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Rodabe N Amaria, Peter A Prieto, Michael T Tetzlaff, Alexandre Reuben, Miles C Andrews, Merrick I Ross, Isabella C Glitza, Janice Cormier, Wen-Jen Hwu, Hussein A Tawbi,[...]. Lancet Oncol 2018
125
6

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
6


Model predicting survival in stage I melanoma based on tumor progression.
W H Clark, D E Elder, D Guerry, L E Braitman, B J Trock, D Schultz, M Synnestvedt, A C Halpern. J Natl Cancer Inst 1989
918
6

Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
Thomas R Crookes, Richard A Scolyer, Serigne Lo, Martin Drummond, Andrew J Spillane. Ann Surg Oncol 2017
13
46

Regional recurrence after negative sentinel lymph node biopsy for melanoma.
Grant W Carlson, Andrew J Page, Cynthia Cohen, Douglas Parker, Ron Yaar, Anya Li, Andrea Hestley, Keith A Delman, Douglas R Murray. Ann Surg 2008
89
6

Complications of sentinel lymph node biopsy for melanoma - A systematic review of the literature.
J A Moody, R F Ali, A C Carbone, S Singh, J T Hardwicke. Eur J Surg Oncol 2017
44
11

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Dale Han, Jonathan S Zager, Yu Shyr, Heidi Chen, Lynne D Berry, Sanjana Iyengar, Mia Djulbegovic, Jaimie L Weber, Suroosh S Marzban, Vernon K Sondak,[...]. J Clin Oncol 2013
150
5

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Michael A Postow, Jason Chesney, Anna C Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P Linette, Nicolas Meyer, Jeffrey K Giguere, Sanjiv S Agarwala,[...]. N Engl J Med 2015
5

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Sandra L Wong, Mark B Faries, Erin B Kennedy, Sanjiv S Agarwala, Timothy J Akhurst, Charlotte Ariyan, Charles M Balch, Barry S Berman, Alistair Cochran, Keith A Delman,[...]. J Clin Oncol 2018
100
5

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
5

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
5

Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
5

Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials.
Georgina V Long, Jean-Jacques Grob, Paul Nathan, Antoni Ribas, Caroline Robert, Dirk Schadendorf, Stephen R Lane, Carmen Mak, Philippe Legenne, Keith T Flaherty,[...]. Lancet Oncol 2016
175
5

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, Michael A Davies, Merrick I Ross, Isabella C Glitza, Janice N Cormier, Carol Lewis, Wen-Jen Hwu, Ehab Hanna,[...]. Nat Med 2018
291
5

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Daniel G Coit, John A Thompson, Mark R Albertini, Christopher Barker, William E Carson, Carlo Contreras, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2019
161
5

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Farhad Azimi, Richard A Scolyer, Pavlina Rumcheva, Marc Moncrieff, Rajmohan Murali, Stanley W McCarthy, Robyn P Saw, John F Thompson. J Clin Oncol 2012
373
5


Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma.
Axel Hauschild, Reinhard Dummer, Dirk Schadendorf, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux,[...]. J Clin Oncol 2018
112
5

Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Adèle C Green, Peter Baade, Michael Coory, Joanne F Aitken, Mark Smithers. J Clin Oncol 2012
111
5

Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.
Yan Xing, Yulia Bronstein, Merrick I Ross, Robert L Askew, Jeffrey E Lee, Jeffrey E Gershenwald, Richard Royal, Janice N Cormier. J Natl Cancer Inst 2011
160
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.